Multielectrode array (MEA) recordings provide a method for studying the electrical activity of large populations of neurons. Here, we present the details of a MEA preparation to record from the mouse vomeronasal epithelium while simultaneously stimulating the tissue.
Part 1. Electrical Recording Instrumentation
Part 2. Liquid Delivery Instrumentation
Part 3. Preparing the MEA and Stimulus Delivery Device
Part 4. VNO Dissection
Part 5. Recording
Part 6. Data Analysis
Part 7. Representative Results
This preparation is typically stable enough to record from for 6 hours, yielding a large amount of data (6 hours of recording from 60 electrodes).
Figure 1. A snapshot of simultaneous activity across one half of the array is shown. The time window spans 400 ms. Please click here to see a larger version of figure 1.
Figure 2. In a typical experiment, we stimulate with particular compounds of interest for 10 seconds. This trace is an example of a response to 100-fold diluted female mouse urine. Please click here to see a larger version of figure 2.
Multielectrode array recordings allow us the ability to monitor the simultaneous activity of a large population of neurons. This is a useful tool for probing the properties of a sensory system, specifically the VNO. Unlike the main olfactory system, the VNO detects stimuli in liquid phase. In addition, the VNO is a heterogeneous tissue. There are approximately 300 different types of receptors in the mouse1, presumably with different response profiles. MEA recordings combined with the robotic arm allow us to reliably deliver liquid stimuli to a large and diverse population of neurons and identity a response electrophysiologically. In addition, the stability of the VNO in vitro allows time for multiple repeats of a stimulus.
Previously, this technique has been used to investigate the sensory properties of VSNs in response to mouse urine2 as well as serve as a reliable assay for identifying individual ligands present in urine3. In the future, this technique may be highly useful to further ligand discovery and in characterizing the sensory properties of the VNO.
We would like to thank members of the Holy Lab. This work was supported by the National Institute for Deafness and Communication Disorders (R01 DC005964 to T.E.H.) and NSF IGERT 0548890 (H.A.A).
Experiments on animals were performed in accordance with the United States Animal Welfare Acts and National Institutes of Health guidelines and were approved by the Washington University Animal Care and Use Committee.